[
    [
        {
            "time": "2021-01-01",
            "original_text": "2021年中国流脑疫苗批签发现状及竞争格局分析 智飞生物比重过半",
            "features": {
                "keywords": [
                    "流脑疫苗",
                    "批签发",
                    "智飞生物",
                    "竞争格局"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2021年中国流脑疫苗批签发现状及竞争格局分析 智飞生物比重过半",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        }
    ]
]